Cargando…
Cost of Oncology Drugs in the Middle-Eastern Country of Lebanon: An Update (2014-2016)
PURPOSE: This study aims to evaluate trends in the increasing costs of oncology drugs procured by the Lebanese Ministry of Public Health (MOPH) between 2014 and 2016 and to assess the impact of the introduction in mid-2015 of new immunotherapy drugs for the treatment of lung cancer on the overall an...
Autores principales: | Elias, Fadia, Bou-Orm, Ibrahim R., Adib, Salim M., Gebran, Selim, Gebran, Anthony, Ammar, Walid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223478/ https://www.ncbi.nlm.nih.gov/pubmed/30241263 http://dx.doi.org/10.1200/JGO.17.00179 |
Ejemplares similares
-
Budget Impact of Treatment-Free Remission in Treating Chronic-Phase Philadelphia-Positive Chronic Myeloid Leukemia in Lebanon
por: Elias, Fadia, et al.
Publicado: (2019) -
Patterns and determinants of mammography screening in Lebanese women
por: Elias, Nadia, et al.
Publicado: (2016) -
Assessment of prescribing information for generic drugs manufactured in the Middle East and marketed in Saudi Arabia
por: Gebran, Nicole, et al.
Publicado: (2006) -
Screening for Cardiovascular Risk in Asymptomatic Users of the Primary Health Care Network in Lebanon, 2012–2013
por: Yamout, Rouham, et al.
Publicado: (2014) -
Possible risk factors involved in psychological and emotional stress
and depression among forensic medicine workers
por: Gebran, Katrin Möbius, et al.
Publicado: (2022)